IP Library Granted Patent US 11,819,328
Granted Patent B2
US 11,819,328 · App. 17/163,173 · Granted Nov 21, 2023

Methods and systems for endobronchial diagnostics

Inventors: Surag Mantri (Sunnyvale, CA); Srikanth Radhakrishnan (Cupertino, CA)
Assignee: Pulmonx Corporation
A61B5/14552A61B1/00082A61B1/2676A61B5/08A61B5/085A61B5/087A61B5/091A61B5/14542A61B5/6853A61M16/0003A61M16/0404A61M2016/0036A61M2016/102A61M2230/205A61M2230/43
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,819,328
App. No.
17/163,173
Granted
Nov 21, 2023
Kind
B2
Abstract

Methods and systems for targeting, accessing and diagnosing diseased lung compartments are disclosed. The method comprises introducing a diagnostic catheter with an occluding member at its distal end into a lung segment via an assisted ventilation device; inflating the occluding member to isolate the lung segment; and performing a diagnostic procedure with the catheter while the patient is ventilated. The proximal end of the diagnostic catheter is configured to be attached to a console. The method may also comprise introducing the diagnostic catheter into the lung segment; inflating the occluding member to isolate the lung segment; and monitoring blood oxygen saturation. The method may further comprise introducing the diagnostic catheter into the lung segment; determining tidal flow volume in the lung segment; determining total lung capacity of the patient; and determining a flow rank value based on the tidal flow volume of the lung segment and the total lung capacity.

Claims (9)

1. A method of assessing the functionality of a lung segment in a patient, the method comprising:

introducing a diagnostic catheter into the lung segment, wherein the diagnostic catheter comprises a distal end comprising an occluding member and a proximal end configured to be attached to a console;

inflating the occluding member to isolate the lung segment;

monitoring blood oxygen saturation of the patient; and

determining functionality of the lung segment based on a rate of change of blood oxygen concentration.

2. The method of claim 1 , wherein the monitoring step comprises monitoring oxygen saturation before and after the inflating step.

3. The method of claim 1 , further comprising deflating the occluding member after the monitoring step.

4. The method of claim 3 , further comprising monitoring oxygen saturation after the deflating step.

5. The method of claim 1 , wherein the monitoring step is conducted by a pulse oximeter.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 073980/0673 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2023
From: MANTRI, SURAG; RADHAKRISHNAN, SRIKANTH
To: PULMONX CORPORATION
Reel/Frame 065254/0986 →
SECURITY INTEREST Recorded Nov 30, 2022
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 061929/0750 →
Continuity (5)
Continuation 16107849 · Aug 21, 2018
Division 14339197 · Jul 23, 2014
Division 13174633 · Jun 30, 2011
Provisional Application 61360811 · Jul 1, 2010
Related Publication 20210177321A1 · Jun 17, 2021
Cited By (1)
US 12,465,249